skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Lamivudine (Code C1471)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Lamivudine

Definition: A synthetic nucleoside analogue with activity against hepatitis B virus (HBV) and HIV. Intracellularly, lamivudine is phosphorylated to its active metabolites, lamiduvine triphosphate (L-TP) and lamiduvine monophosphate (L-MP). In HIV, L-TP inhibits HIV-1 reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleoside analogue into viral DNA. In HBV, incorporation of L-MP into viral DNA by HBV polymerase results in DNA chain termination. L-TP is a weak inhibitor of mammalian DNA polymerases alpha and beta, and mitochondrial DNA polymerase. (NCI04)

NCI-GLOSS Definition: A drug used to treat infection caused by viruses.

Display Name: Lamivudine

Label: Lamivudine

NCI Thesaurus Code: C1471 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0209738  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)

External Source Codes: 
CAS Registry Number 134678-17-4 (see NLM ChemIDplus info)
FDA UNII Code 2T8Q726O95
ChEBI ID CHEBI:63577 (see ChEBI info)
PDQ Closed Trial Search ID 42593
PDQ Open Trial Search ID 42593 (check for NCI PDQ open clinical trial info)
UMLS CUI C0209738

Other Properties:
     Name Value (qualifiers indented underneath)
Accepted_Therapeutic_Use_For Chronic hepatitis B; HIV infection
Chemical_Formula C8H11N3O3S
code C1471
Contributing_Source CTRP
Contributing_Source FDA
Legacy_Concept_Name Lamivudine
Semantic_Type Nucleic Acid, Nucleoside, or Nucleotide
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom